Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded
Currently Indefinitely Postponed
Email me when SB 351 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 351. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would let any FDA‑approved single‑dose pre‑measured epinephrine product, not just autoinjectors, be carried, stocked, and used by K‑12 schools, authorized entities and certain staff. It creates prescription, dispensing, storage, training and immunity rules, and would become effective on October 1, 2026. The measure failed and is indefinitely postponed.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 351
3 free questions a day, no accountHearings
- Healthcare Standing MeetingSenate Healthcare · Mar 17, 2026
History
- Currently Indefinitely Postponed
- Reported Out of Committee House of Origin
- Read for the Second Time and placed on the Calendar (Healthcare)
- Read for the first time and referred to the Senate Committee on Healthcare
- Pending Committee Action in House of Origin (Healthcare)
Sponsors
- April Weaver (R) · sponsor
- Weaver
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 351 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 351 freeOr ask your AI assistant about SB 351 directly:
Add to Claude, ChatGPT or Cursor